Comparing Vonoprazan vs. Pantoprazole for GERD
Treatments studied
Part of Digestive system clinical trials.
This trial tests a newer medication called vonoprazan against the standard treatment pantoprazole for patients with gastroesophageal reflux disease (GERD). The goal is to see which one works better for controlling symptoms like heartburn and acid reflux over 8 weeks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 17 and 60 years old.
- You have a GERD symptom score of 8 or more on a standard questionnaire.
- You have not had past stomach or esophagus surgery, or conditions like Barrett's esophagus.
- You are not pregnant or breastfeeding.
- Your liver and kidney function tests are within a certain range.
- You are not taking specific HIV medications that might interfere with the study drugs.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a newer medicine, tegoprazan, works better than an older one, pantoprazole, for treating heartburn and acid reflux. Both are stomach acid reducers. You may be able to join if you have been diagnosed with GERD and your symptoms have lasted for at least three months.
This trial tests a medicine called vonoprazan for people whose acid reflux symptoms (like heartburn or coughing) don't get better with usual treatment. It aims to see if vonoprazan can help control those symptoms.
This trial tests vonaprazan (two doses) against esomeprazole to see which better heals moderate-to-severe reflux esophagitis (a damaged esophagus from acid reflux) in 8 weeks. You may qualify if you have had heartburn or regurgitation for at least a month and your doctor found grade B, C, or D damage on an endoscopy.
This trial compares two medicines—vonoprazan and esomeprazole—to see which is better at healing acid damage to the esophagus (erosive esophagitis). If you have had heartburn and an endoscopy confirmed inflammation, you may be eligible for this study.
This study compares two acid-reducing medications, keverprazan and pantoprazole, to see which is better at stopping bleeding from the upper digestive tract (stomach or food pipe). If you have had bleeding in your stomach or intestines, this trial could help determine the most effective treatment for you.
This trial tests whether a heartburn medication (pantoprazole) helps patients with liver cirrhosis who have had a procedure to treat enlarged veins in the esophagus or stomach. It looks at how well the medicine works when given after this procedure to prevent complications.
Hear when a new Gastroesophageal Reflux Disease (GERD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.